{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:53:23Z","timestamp":1787018003448,"version":"build-2736575974"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1999,10]]},"abstract":"<jats:p>\n                    <jats:italic>Abstract<\/jats:italic>\n                    \u2014In this review, we examine the possibility that small increments in angiotensin II are responsible for an increase in blood pressure and maintenance of hypertension through the stimulation of oxidative stress. A low dose of angiotensin II (2 to 10 ng \u00b7 kg\n                    <jats:sup>\u22121<\/jats:sup>\n                    \u00b7 min\n                    <jats:sup>\u22121<\/jats:sup>\n                    , which does not elicit an immediate pressor response), when given for 7 to 30 days by continuous intravenous infusion, can increase mean arterial pressure by 30 to 40 mm Hg. This slow pressor response to angiotensin is accompanied by the stimulation of oxidative stress, as measured by a significant increase in levels of 8-iso-prostaglandin F\n                    <jats:sub>2\u03b1<\/jats:sub>\n                    (F\n                    <jats:sub>2<\/jats:sub>\n                    -isoprostane). Superoxide radicals and nitric oxide can combine chemically to form peroxynitrite, which can then oxidize arachidonic acid to form F\n                    <jats:sub>2<\/jats:sub>\n                    -isoprostanes. F\n                    <jats:sub>2<\/jats:sub>\n                    -isoprostanes exert potent vasoconstrictor and antinatriuretic effects. Furthermore, angiotensin II can stimulate endothelin production, which also has been shown to stimulate oxidative stress. In this way, a reduction in the concentration of nitric oxide (which is quenched by superoxide) along with the formation of F\n                    <jats:sub>2<\/jats:sub>\n                    -isoprostanes and endothelin could potentiate the vasoconstrictor effects of angiotensin II. We hypothesize that these mechanisms, which underlie the development of the slow pressor response to angiotensin II, also participate in the production of hypertension when circulating angiotensin II levels appear normal, as occurs in many cases of essential and renovascular hypertension.\n                  <\/jats:p>","DOI":"10.1161\/01.hyp.34.4.943","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T20:53:46Z","timestamp":1339448026000},"page":"943-949","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":249,"title":["Role of Angiotensin and Oxidative Stress in Essential Hypertension"],"prefix":"10.1161","volume":"34","author":[{"given":"J. Carlos","family":"Romero","sequence":"first","affiliation":[{"name":"From the Department of Physiology and Biophysics, Mayo School of Medicine and Division of Hypertension, Mayo Clinic (J.C.R.) Rochester, Minn; and the Department of Physiology and Biophysics and the Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center (J.F.R.), Jackson, Miss."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane F.","family":"Reckelhoff","sequence":"additional","affiliation":[{"name":"From the Department of Physiology and Biophysics, Mayo School of Medicine and Division of Hypertension, Mayo Clinic (J.C.R.) Rochester, Minn; and the Department of Physiology and Biophysics and the Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center (J.F.R.), Jackson, Miss."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"151","volume":"17","year":"1999","unstructured":"1999 World Health Organization\u2013International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17:151\u2013183.","journal-title":"J Hypertens"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0790193"},{"key":"e_1_3_2_3_2","first-page":"141","volume":"1","year":"1984","unstructured":"Laragh JH. The meaning of plasma renin measurements: renin and sodium volume-mediated (low renin) forms of vasoconstriction in experimental and human hypertension and in the oedematous states of nephrosis and heart failure. J Hypertens. 1984;1:141\u2013150.","journal-title":"J Hypertens"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-90-1-19"},{"key":"e_1_3_2_5_2","unstructured":"Nelson EB Harm SC Goldberg M Shahinfar S Goldberg A Sweet CS. Clinical profile of the first angiotensin II (AT-1 specific) receptor antagonists. In: Laragh JH Brenner BM eds. Hypertension Pathophysiology Diagnosis and Management. 2nd ed. New York NY: Raven Press; 1995:2895\u20132916."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118623"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/2.5.358"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Dickinson CJ Oxon DM Lawrence JR Adelaide MB. A slowly developing pressor response to small concentrations of angiotensin: its bearing on the pathogenesis of chronic renal hypertension. Lancet. 1963;I:1354\u20131356.","DOI":"10.1016\/S0140-6736(63)91929-9"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.149.3690.1394"},{"key":"e_1_3_2_10_2","unstructured":"Lever AF. The fast and the slowly developing pressor effect of angiotensin II. In: Ian J Robertson S Nicholls MG eds. The Renin-Angiotensin System. London UK: Gower Medical Publishing; 1993:28.1\u201328.9."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/144980a0"},{"key":"e_1_3_2_12_2","unstructured":"Griendling KK Alexander RW. Cellular mechanisms of angiotensin II action. In: Swales JD ed. Textbook of Hypertension. Oxford UK: Blackwell Scientific Publishing; 1994:244\u2013253."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105224"},{"key":"e_1_3_2_14_2","first-page":"H381","volume":"241","year":"1981","unstructured":"Brown AJ, Casals-Stenzel J, Gofford S, Lever AJ, Morton JJ. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol. 1981;241:H381\u2013H388.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Haas JA Krier JD Bolterman RJ Romero JC. Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension. 1999;33:1079.","DOI":"10.1161\/01.HYP.34.4.983"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.44.4.428042"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198101000-00016"},{"key":"e_1_3_2_18_2","first-page":"H683","volume":"246","year":"1984","unstructured":"Zabludowski J, Clark S, Ball SG, Brown AJ, Inglis GC, Lever AF, Murray G. Pressor effects of brief and prolonged infusions of epinephrine in the conscious rat. Am J Physiol. 1984;246:H683\u2013H689.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0022-3565(25)23835-6","volume":"271","year":"1994","unstructured":"Gorbea-Oppliger VJ, Melaragno MG, Potter GS, Petit RL, Fink GD. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects. J Pharmacol Exp Ther. 1994;271:804\u2013810.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.24.7812"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)89121-9"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.7.3.447"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)38468-5"},{"key":"e_1_3_2_24_2","first-page":"F759","volume":"250","year":"1986","unstructured":"Smith JB. Angiotensin-receptor signaling in cultured vascular smooth muscle cells. Am J Physiol. 1986;250:F759\u2013F769.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1984.64.3.938"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V7102025"},{"key":"e_1_3_2_27_2","first-page":"L699","volume":"268","year":"1995","unstructured":"Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. 1995;268:L699\u2013L722.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(93)90010-M"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.361"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(90)90115-I"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115826"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1993.264.6.C1619"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199526003-00016"},{"key":"e_1_3_2_34_2","first-page":"L768","volume":"273","year":"1997","unstructured":"Michael JR, Markewitz BA, Kohan DE. Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells. Am J Physiol. 1997;273:L768\u2013L774.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.4065\/72.3.251"},{"key":"e_1_3_2_36_2","first-page":"21","volume":"16","year":"1996","unstructured":"Shanley PF. The pathology of chronic renal ischemia. Semin Nephrol. 1996;16:21\u201332.","journal-title":"Semin Nephrol"},{"key":"e_1_3_2_37_2","first-page":"33","volume":"16","year":"1996","unstructured":"Kellerman PS. Cellular and metabolic consequences of chronic ischemia on kidney function. Semin Nephrol. 1996;16:33\u201342.","journal-title":"Semin Nephrol"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.31.1.283"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114477"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(05)80064-6"},{"key":"e_1_3_2_41_2","first-page":"S169","volume":"17","year":"1991","unstructured":"Hirata Y, Matsuoka H, Kimura K, Sugimoto T, Hayakawa H, Suzuki E, Sugimoto T. Role of endothelium-derived relaxing factor in endothelin-induced renal vasoconstriction. J Cardiovasc Pharmacol.. 1991;17:S169.","journal-title":". J Cardiovasc Pharmacol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.85.5.1572045"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V651476"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.91.3.771"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00216-8"},{"key":"e_1_3_2_46_2","unstructured":"Best PJM Lerman LO Romero JC Holmes DR Jr Lerman A. Chronic endothelin receptor antagonism preserves coronary nitric oxide activity in experimental hypercholesterolemia. Arterioscler Thromb Vasc Biol. In press."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1991.sp018412"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1992.263.2.C516"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(90)90002-Q"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02532843"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7827(97)00001-5"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.23.9383"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116143"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505043321804"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.22.10721"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(05)70255-7"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(94)90128-7"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1998.274.5.L767"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1993.74.1.460"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1992.263.3.C660"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(92)90077-7"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.48.32009"},{"key":"e_1_3_2_63_2","first-page":"L437","volume":"273","year":"1997","unstructured":"Davidson CA, Kaminski PM, Wolin MS. NO elicits prolonged relaxation of bovine pulmonary arteries via endogenous peroxynitrite generation. Am J Physiol. 1997;273:L437\u2013L444.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(96)00254-4"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1996.271.4.C1262"},{"key":"e_1_3_2_66_2","first-page":"151","volume":"8","year":"1999","unstructured":"Benkusky NA, Lewis SJ, Kooy NW. Peroxynitrite-mediated attenuation of alpha- and beta-adrenoceptor agonist-induced vascular responses in vivo. Eur J Pharmacol. 1999;8:151\u2013158.","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_2_67_2","first-page":"H501","volume":"275","year":"1998","unstructured":"Benkusky NA, Lewis SJ, Kooy NW. Attenuation of vascular relaxation after development of tachyphylaxis to peroxynitrite in vivo. Am J Physiol. 1998;275:H501\u2013H507.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","unstructured":"Villa LM Salas E Darley-Usmar VM Radomski MW Moncada S. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci USA. 1994;91:12383\u201312387.","DOI":"10.1073\/pnas.91.26.12383"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702434"},{"key":"e_1_3_2_70_2","unstructured":"Guyton AC Cowley AW Jr Coleman TG Liard JF McCaa RE Manning RD Jr Norman RA Jr Young DB. Pretubular versus tubular mechanisms of renal hypertension. Excerpta Medica International Congress Series No. 302. 1973;15\u201329."},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.43.4.688554"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.14.4.396"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.27.5.1173"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.32.1.59"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.34.4.943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T17:22:22Z","timestamp":1743355342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.34.4.943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["10.1161\/01.HYP.34.4.943"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.34.4.943","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10]]},"assertion":[{"value":"1999-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-07-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}